Nicole Long, DO
Obstetrics & Gynecology · Abingdon, VANPI 1962609289
Payments from drug & device makers
Across 200 payments — averaging $23.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- AbbVie$852
- Astellas Pharma US Inc$549
- Mayne Pharma Commercial LLC$359
- Pfizer$245
- Exeltis, USA Inc.$236
- plus $945 from 22 others
What the payments were for
- Travel & lodging$1,01422%
- Food & beverage$3,52276%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $1,449 |
| AbbVie | 52 | $852 |
| Astellas Pharma US Inc | 27 | $549 |
| Mayne Pharma Commercial LLC | 18 | $359 |
| Pfizer | 17 | $245 |
| Exeltis, USA Inc. | 14 | $236 |
| Novo Nordisk | 9 | $138 |
| Amgen | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $98 |
| Lilly USA, LLC | 5 | $80 |
| Therapeuticsmd, Inc. | 5 | $77 |
| Coloplast | 1 | $53 |
| Biogen | 2 | $42 |
| Organon | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Novartis | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Minerva Surgical, Inc | 2 | $28 |
| Merck | 2 | $27 |
| Shield Therapeutics Inc | 1 | $26 |
| Applied Medical Resources Corporation | 1 | $22 |
| Avion Pharmaceuticals | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Bayer | 1 | $16 |
| Axonics, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solyx SIS System$156
- BIJUVA$125
- Orilissa$115
How this compares
$4,635 in reported general payments places this provider in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 48 | $16,512 |
| MyrbetriqMirabegron | 30 | $15,678 |
| GemtesaVibegron | 11 | $5,032 |
| Estradiol | 121 | $2,946 |
| OsphenaOspemifene | 12 | $2,816 |
| Solifenacin Succinate | 32 | $1,441 |
| Norethindrone Acetate | 39 | $1,378 |
| DottiEstradiol | 11 | $701 |
| Clobetasol Propionate | 28 | $594 |
| Oxybutynin Chloride ErOxybutynin Chloride | 41 | $476 |
| Nystatin | 24 | $402 |
| Metronidazole | 11 | $358 |
| Alendronate Sodium | 114 | $327 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $310 |
| Medroxyprogesterone Acetate | 36 | $286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $245 | $16,51248 claims |
| Astellas Pharma US IncMyrbetriq | $549 | $15,67830 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $37 | $5,03211 claims |
| Duchesnay USA IncorporatedOsphena | $11 | $2,81612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Abingdon
- Franklin MorganNorfolk$3.6M
- Samuel CampbellRichmond$1.5M
- Thomas KimbleNorfolk$1M
- Camilla HershReston$912K
- Stephen PoundNorth Chesterfield$548K
- Prescott PrillamanRichmond$329K
- Jack AyoubLeesburg$286K
- Chul KimFalls Church$250K
- Kurian ThottStafford$216K
- John PartridgeRichmond$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.